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) plus AMRU-I from Aotus T1752 ( Supplementary Fig. 1e ). Once gametocytes were observed in thin blood smears, Anopheles mosquitoes were fed on six occasions (points 1 -6 in the graph) and blood samples were simultaneously taken to test for microsatellite alleles from parental lines. A single 2.7 mg/kg CQ dose was administered after mosquito feeding 2 to increase the numbers of CQ-resistant parental parasites without killing CQ-sensitive (CQ-S) parasites. Malarone treatment was administered for three days (arrow indicates day of first dose) to the chimpanzee after mosquito feeding 6 to cure the infection.
Parasitemia values are provided in Supplementary Table 3 (PP1), collected from the chimpanzee at peak parasitemia (0.14%) on the 15 th day post sporozoite inoculation (DPSI), were used to infect Aotus T1261, 85997, and 86027. Parasites were observed in blood smears from these Aotus in 10 -14 days. After collection and cryopreservation of blood samples, the PP1 infections were treated with 15 mg/kg total CQ (Supplementary Table 8 ); no recrudescences were observed in the 62-day follow-up period.
Sub-inoculation of the Aotus T1261, 85997, and 86027 samples into three monkeys produced infections in Aotus 86121 and Saimiri 5081 but not in Saimiri 4898. These two successful infections were treated with 2 or 3 courses of CQ treatment (Supplementary Fig. 4) , and recrudescent parasites were recovered from each animal for analysis and cryopreservation.
Parasites from chimpanzee Progeny Pool 2 (PP2) were inoculated into Aotus 85891, 85922, 85748, 86013 and T1727. All five monkeys developed parasitemias in 11 -16 days.
After collection and cryopreservation of blood samples, these PP2 infections were treated with 15 mg/kg total CQ ( Supplementary Table 8 ) after which recrudescences occurred in Aotus 85891 and 85922 ( Supplementary Fig. 4 ). Cryopreserved stocks from the PP2-infected monkeys were sub-inoculated as indicated into Aotus WR454, 85986, 85823, 85850, 85741, and Saimiri 5076 and 4919. Parasitemias in six of these sub-inoculated monkeys recrudesced after CQ total doses of 15 -55 mg/kg (Aotus WR454, 85986, 85823, 85850, and Saimiri 5076 and 4919; Supplementary Fig. 4 ; Supplementary Table 8 ).
Ten of the 17 monkey infections provided recrudescent PP1 or PP2 populations for linkage group selection analysis (highlighted in gray). Inoculation of chimpanzee Progeny Pool 3 (PP3) samples into two Aotus did not produce a parasitemia or PCR signal of infection in either monkey.
Supplementary Figure 4. Recrudescences after CQ treatment of Aotus and Saimiri
monkeys infected with NIH-1993 S×R progeny pools PP1 or PP2. Each monkey received a total CQ dose of at least 15 mg/kg CQ. The parasitemia data for the graphs are provided in Supplementary Table 7 . PCR + indicates detection by PCR but not by microscopy of blood smears. * Parasites from this post-CQ feeding infected mosquitoes were at levels too low to obtain sporozoites for cryopreservation.
Supplementary Figure 6
Viability of fresh and cryopreserved sporozoites were determined in hepatocyte invasion assays as described 8 .
DPSI, days post sporozoite inoculation. Fig. 4 . DPBI, days post blood inoculation. Cells are highlighted according to the antimalarial drug and dose given on indicated day: red, 2.5 mg/kg CQ; green, 5 mg/kg CQ; blue, 10 mg/kg CQ.
Supplementary
32 Supplementary Table 8 ID, animal identification number; DPBI, days post blood inoculation; CQ, chloroquine; DUL, detected under the limit of quantification; ND, not detected. "Treatment Initiation" refers to the first day CQ was given for the corresponding dose treatment administration; "Plasma Collection" refers to the day blood was collected for plasma separation and CQ measurement. 

